Document Detail

Successful management of supraventricular tachycardia in a fetus using fetal magnetocardiography.
MedLine Citation:
PMID:  16113573     Owner:  NLM     Status:  MEDLINE    
We report a fetus at 33 weeks of gestation with supraventricular tachycardia, which was successfully managed by transplacental administration of an antiarrhythmic agent. Fetal magnetocardiography (fMCG) revealed supraventricular tachycardia of the long RP' tachycardia type. Transplacental administration of sotalol, instead of digoxin, was selected as the first-line drug, and it successfully converted supraventricular tachycardia to sinus rhythm. The diagnosis of the type of supraventricular tachycardia was confirmed by electrocardiography after birth. Sotalol was also effective after birth to maintain sinus rhythm. This case demonstrates that fMCG is potentially useful for prenatal differentiation of the type of supraventricular tachycardia and for prenatal treatment of fetal tachyarrhythmias.
Kanako Abe; Hiromi Hamada; Yang-Jen Chen; Azusa Abe; Hideki Watanabe; Yutaka Fujiki; Hiroyuki Yoshikawa; Takashi Murakami; Hitoshi Horigome
Related Documents :
23161263 - Position of the conus medullaris in fetuses with skeletal dysplasia.
8904423 - Comparative evaluation of virological and serological methods in prenatal diagnosis of ...
18685903 - Pregnancy following gastric bypass for morbid obesity: effect of surgery-to-conception ...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Fetal diagnosis and therapy     Volume:  20     ISSN:  1015-3837     ISO Abbreviation:  Fetal. Diagn. Ther.     Publication Date:    2005 Sep-Oct
Date Detail:
Created Date:  2005-08-22     Completed Date:  2005-12-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9107463     Medline TA:  Fetal Diagn Ther     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  459-62     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2005 S. Karger AG, Basel.
Department of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Arrhythmia Agents / administration & dosage*
Electrophysiologic Techniques, Cardiac
Fetal Diseases / drug therapy*
Infant, Newborn
Prenatal Diagnosis
Sotalol / administration & dosage*
Tachycardia, Supraventricular / diagnosis*,  drug therapy*
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 3930-20-9/Sotalol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Is conservative management of prenatal and neonatal ovarian cysts justifiable?
Next Document:  Preimplantation genetic diagnosis of Canavan disease.